#United States #New York #Class Action #The Gross Law Firm #Replimune Group

Class Action Lawsuit Filed Against Replimune Group, Inc. (REPL)

On August 11, 2025, The Gross Law Firm announced an important notice concerning a class action lawsuit against Replimune Group, Inc. (NASDAQ: REPL). This notice is particularly directed at shareholders who purchased shares during the specified class period, running from November 22, 2024, to July 21, 2025. The firm encourages eligible shareholders to contact them regarding the appointment of a lead plaintiff. However, note that being appointed as a lead plaintiff is not a prerequisite for participating in any potential recovery from the lawsuit.

Background of the Case

The allegations presented in the complaint assert that during the stated class period, Replimune's executives made materially false and/or misleading statements regarding the prospects of their IGNYTE trial. Significant concerns had emerged that, according to the lawsuit, the defendants knew or should have known about. The primary issues raised point to the trial being deemed inadequate and inadequately controlled by the FDA, leading to heightened concerns about the company's reporting on its business, operations, and future outlook.

These allegations have sparked considerable interest and concern among shareholders who are encouraged to act promptly to ensure their rights are protected. The last date for shareholders to register for the class action lawsuit is September 22, 2025. It is crucial not to delay registration to secure a position as a participant in this ongoing legal battle.

Next Steps for Shareholders

Once individuals register as shareholders who purchased REPL shares during the designated timeframe, they will gain access to a portfolio monitoring software. This software offers continual status updates about the lawsuit’s progress throughout its lifecycle. Shareholders should be aware that although they are invited to seek the position of lead plaintiff, it is not a requirement for participation. No fees or obligations are attached to registering in this instance.

Why Choose The Gross Law Firm?

The Gross Law Firm prides itself on being a nationally-recognized entity specializing in class action lawsuits. Their mission is to protect the rights of investors who have suffered losses due to fraudulent activities, deceit, or illegal conduct. They are committed to holding companies accountable for responsible business practices and ensuring they maintain ethical corporate citizenship. The Gross Law Firm actively seeks recovery on behalf of investors who have been affected by misleading announcements or withheld crucial information that may have contributed to unreasonably inflated stock prices.

Conclusion

In light of the ongoing developments in the lawsuit against Replimune Group, Inc., affected shareholders are urged to act swiftly. Contacting The Gross Law Firm is a vital step for investors looking to stay updated and preserve their rights in this ever-evolving situation. Whether or not a lead plaintiff position is pursued, participation in this class action can make a significant difference in addressing the concerns around the company's alleged misstatements and operational transparency.

For additional information and to register, interested shareholders are advised to reach out to The Gross Law Firm at their New York office, or through their provided website links.

Contact Information:
Email: [email protected]
Phone: (646) 453-8903
Address: 15 West 38th Street, 12th floor, New York, NY, 10018.